Glycopyrrolate Injection
Product Images NDC 51662-1601

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 51662-1601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Labeling (51662 1601 1 Serialized Vial Labeling)

Serialized Labeling (51662 1601 1 Serialized Vial Labeling)
GLYCOPYRROLATE injection 0.2 mg/mL vial with orange cap, labeled for intravenous and intramuscular use. The vial includes manufacturer information for HF Acquisition Co LLC, DBA HealthFirst. Packaging includes a white label with text and a barcode.*
FDA Label Image

Clinical (Clinical)

Clinical (Clinical)
A pharmacokinetic data table showing parameters for Glycopyrrolate administered intravenously (6 µg/kg IV) and intramuscularly (8 µg/kg IM). It includes values for half-life (t1/2), volume of distribution at steady state (Vss), clearance (CL), time to maximum concentration (Tmax), maximum concentration (Cmax), and area under the curve (AUC), with associated error margins and notes.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of glycopyrrolate displaying its molecular formula C19H28BrNO3 and molecular weight 398.33. The diagram shows the arrangement of atoms including a bromide ion associated with the quaternary ammonium group.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL in 5 mL multiple dose vial. The label states it is for intramuscular or intravenous use and contains benzyl alcohol as preservative. Storage instructions specify 20° to 25°C. Distributed by Hikma under labeler HF Acquisition Co LLC, DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.